Prospera Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26.1M Buy
378,006
+275,104
+267% +$19M 0.49% 39
2025
Q1
$7.15M Buy
102,902
+5,701
+6% +$396K 0.16% 137
2024
Q4
$8.36M Buy
97,201
+10,731
+12% +$923K 0.19% 120
2024
Q3
$10.3M Buy
86,470
+10,562
+14% +$1.26M 0.26% 81
2024
Q2
$10.8M Buy
75,908
+6,250
+9% +$892K 0.3% 74
2024
Q1
$8.94M Sell
69,658
-8,203
-11% -$1.05M 0.27% 81
2023
Q4
$8.05M Buy
77,861
+2,831
+4% +$293K 0.27% 78
2023
Q3
$6.82M Buy
75,030
+2,670
+4% +$243K 0.26% 83
2023
Q2
$5.86M Buy
72,360
+26,352
+57% +$2.13M 0.22% 109
2023
Q1
$3.66M Sell
46,008
-600
-1% -$47.7K 0.15% 165
2022
Q4
$3.15M Buy
46,608
+1,766
+4% +$120K 0.16% 152
2022
Q3
$2.23M Sell
44,842
-8,626
-16% -$430K 0.12% 216
2022
Q2
$2.98M Buy
53,468
+2,500
+5% +$139K 0.15% 171
2022
Q1
$2.83M Buy
50,968
+20,146
+65% +$1.12M 0.12% 215
2021
Q4
$1.73M Sell
30,822
-1,974
-6% -$111K 0.07% 296
2021
Q3
$1.57M Sell
32,796
-566
-2% -$27.2K 0.08% 289
2021
Q2
$1.4M Buy
33,362
+28
+0.1% +$1.17K 0.07% 318
2021
Q1
$1.12M Buy
33,334
+4,310
+15% +$145K 0.07% 316
2020
Q4
$1.01M Buy
29,024
+27,160
+1,457% +$949K 0.07% 295
2020
Q3
$65K Sell
1,864
-26,074
-93% -$909K 0.02% 533
2020
Q2
$915K Buy
27,938
+2,884
+12% +$94.5K 0.08% 245
2020
Q1
$754K Sell
25,054
-1,068
-4% -$32.1K 0.08% 235
2019
Q4
$756K Buy
26,122
+7,860
+43% +$227K 0.06% 300
2019
Q3
$472K Sell
18,262
-5,886
-24% -$152K 0.05% 320
2019
Q2
$611K Buy
24,148
+8,946
+59% +$226K 0.07% 244
2019
Q1
$390K Buy
15,202
+4,966
+49% +$127K 0.13% 206
2018
Q4
$242K Buy
+10,236
New +$242K 0.05% 331